News & Events

  • We are proud to announce that BioXtreme is awarded a R&D grant from the Israel Innovation Authority


    Click here to read more

  • BioXtreme and Heliomare rehabilitation centre will conduct a joint clinical trial research project on deXtreme™ in Heliomare facility in the Netherlands


    Click here to read more

  • BioXtreme is proud to announce that our product, deXtreme™ is FDA registered!


    Registration took place at 17/2/2020. BioXtreme’s FDA owner/operator number is 10062549

  • BioXtreme will exhibit in 11th World Congress for Neurorehabilitation

    07-10/10/2020, Lyon France
    Please join us at booth #47
  • BioXtreme will showcase deXteme™ 3.0 in the upcoming European Neuro Convention

    09/11-10/03/2021, Birmingham UK
    Come join us in booth #316